Dr. Gruber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2014 - 2017
- University of Kansas School of MedicineClass of 2014
Certifications & Licensure
- MN State Medical License 2015 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- The clinical presentation of PIT1 positive pituitary neuroendocrine tumor immunonegative for growth hormone, prolactin, and thyroid stimulating hormone with analysis o...Hong, S., Shinya, Y., Trejo-Lopez, J., Gruber, L., Erickson, D., Bendok, B., Chaichana, K., Atkinson, J., Marino, M., Donaldson, A., Stokken, J., Westphal, S., Chang, ...> ;Clinical Neurology and Neurosurgery. 2024 Jan 1
- Use of overnight metyrapone test in suspected secondary adrenal insufficiency: A retrospective single centre-study.Jasmine Saini, Raul Gregg Garcia, Justine Herndon, Dana Erickson, Lucinda Gruber, Irina Bancos> ;Clinical Endocrinology. 2024 Mar 1
- 2 citationsLong-term outcomes among adults with Langerhans cell histiocytosis.Gaurav Goyal, Aldo A Acosta-Medina, Jithma P Abeykoon, Chen Dai, Aishwarya Ravindran, Robert Vassallo, Jay H Ryu, Mithun V Shah, N Nora Bennani, Jason R Young, Corrie ...> ;Blood Advances. 2023 Nov 14
- Join now to see all
Authored Content
- Predicting Genotype with Phenotype Predicts Genotype: Pheochromocytoma and ParagangliomaFebruary 2018
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: